Bio-Techne (TECH) Inventory Average (2010 - 2026)
Bio-Techne (TECH) posted quarterly Inventory Average of $203.3 million for Q1 2026, up 7.16% year-over-year from $189.7 million in Q1 2025, and little changed quarter-over-quarter from $204.3 million in Q4 2025.
Bio-Techne (TECH) Inventory Average (2010 - 2026) Analysis & Trends
Bio-Techne's Inventory Average history runs 17 years deep, the most recent figure standing at $203.3 million for Q1 2026.
- In Q1 2026, Inventory Average rose 7.16% year-over-year to $203.3 million; the TTM figure through Mar 2026 stood at $203.3 million (up 7.16% YoY), while the FY2025 annual figure was $184.6 million, up 5.07% from the prior year.
- Inventory Average for Q1 2026 stood at $203.3 million, roughly flat from $204.3 million in the prior quarter.
- The five-year high for Inventory Average was $204.3 million in Q4 2025, with the low at $125.1 million in Q1 2022.
- The 5-year median for Inventory Average is $180.2 million (2024), against an average of $174.8 million.
- The sharpest annual moves came in 2023 and 2024: Inventory Average surged 31.8% in 2023, then rose 1.77% in 2024.
- Bio-Techne's Inventory Average stood at $155.1 million in 2022, then increased by 18.27% to $183.5 million in 2023, then rose by 1.77% to $186.7 million in 2024, then advanced by 9.43% to $204.3 million in 2025, then fell by 0.49% to $203.3 million in 2026.
- Business Quant data shows TECH's Inventory Average at $203.3 million in Q1 2026, $204.3 million in Q4 2025, and $196.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Bio-Techne | 11.33 Bn | 11.12 Bn | 208.29 Mn | 203.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 203.31 Mn |
| Dec 31, 2025 | 204.32 Mn |
| Sep 30, 2025 | 196.32 Mn |
| Jun 30, 2025 | 190.26 Mn |
| Mar 31, 2025 | 189.73 Mn |
| Dec 31, 2024 | 186.71 Mn |
| Sep 30, 2024 | 182.39 Mn |
| Jun 30, 2024 | 179.61 Mn |
| Mar 31, 2024 | 180.17 Mn |
| Dec 31, 2023 | 183.46 Mn |
| Sep 30, 2023 | 178.86 Mn |
| Jun 30, 2023 | 170.55 Mn |
| Mar 31, 2023 | 164.85 Mn |
| Dec 31, 2022 | 155.12 Mn |
| Sep 30, 2022 | 145.57 Mn |
| Jun 30, 2022 | 134.70 Mn |
| Mar 31, 2022 | 125.07 Mn |
| Dec 31, 2021 | 119.61 Mn |
| Sep 30, 2021 | 117.06 Mn |
| Jun 30, 2021 | 113.37 Mn |